Back to results
US 5,217,953 AGranted
Vasoactive intestinal peptide antagonist
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsIllana Gozes, Douglas E. Brenneman, Mati M. Fridkin, Terry Moody
Life of this patent
Estimating the term…
Abstract
The present invention relates to a peptide encoding an antagonist of VIP. The invention also relates to a method of using said peptide to antagonize VIP function. The invention further relates to a pharmaceutical composition.
Claims3
A vasoactive intestinal polypeptide (VIP) antagonist, said antagonist having the following amino acid sequence (Seq. I.D. No. 2):
- ##STR1##
Dependencies are inferred from the claim text.